The equilibrative nucleoside transporter family, SLC29

Pflugers Archiv European Journal of Physiology

Volumn 447, Issue 5, 2004, Pages 735-743

  Baldwin, Stephen A ^a   Beal, Paul R ^a   Yao, Sylvia Y M ^b   King, Anne E ^a   Cass, Carol E ^b   Young, James D ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adenosine; Cancer; Cardiovascular; ENT; Equilibrative; Nitrobenzylthioinosine; Nucleoside; Transporter

Indexed keywords

ADENOSINE; CAPECITABINE; CLADRIBINE; CORONARY VASODILATING AGENT; CYTARABINE; DILAZEP; DIPYRIDAMOLE; DRAFLAZINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 3; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 4; FLUDARABINE; GEMCITABINE; IMATINIB; LIDOFLAZINE; MEMBRANE PROTEIN; NUCLEOBASE TRANSPORTER; NUCLEOSIDE TRANSPORTER; PURINE NUCLEOSIDE; PYRIMIDINE NUCLEOSIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CYTOPLASM; DRUG UPTAKE; EPITHELIUM; EUKARYOTE; HUMAN; LYSOSOME MEMBRANE; MULTIGENE FAMILY; MUTATION; NEUROTRANSMISSION; NONHUMAN; NUCLEOSIDE TRANSPORT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; STRUCTURE ANALYSIS; VIRUS INFECTION;

ANIMALS; BIOLOGICAL TRANSPORT; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS; HUMANS; MULTIGENE FAMILY; NUCLEOSIDES;

EID: 1242272722     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00424-003-1103-2     Document Type: Review

References (55)

1. Acimovic Y, Coe IR (2002) Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes. Mol Biol Evol 19:2199-2210
2. Ackley MA, Governo RJ, Cass CE, Young JD, Baldwin SA, King A (2003) Control of glutamatergic neurotransmission in the rat spinal dorsal horn by the nucleoside transporter ENT1. J Physiol (Lond) 548:507-517
3. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402
4. Baldwin SA, Mackey JR, Cass CE, Young JD (1999) Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 5:216-224
5. Baxter G (2002) Role of adenosine in delayed preconditioning of myocardium. Cardiovasc Res 55:483-494
6. Berry ZA (2002) Nucleoside transporters in the heart. PhD Thesis, University of Leeds
7. Clarke ML, Mackey JR, Baldwin SA, Young JD, Cass CE (2002) The role of membrane transporters in cellular resistance to anticancer nucleoside drugs. In: Andersson B, Murray D (eds) Clinically relevant resistance in cancer chemotherapy. Kluwer, Boston, pp 27-47
8. Coe I, Zhang Y, McKenzie T, Naydenova Z (2002) PKC regulation of the human equilibrative nucleoside transporter, hENT1. FEBS Lett 517:201-205
9. Crawford CR, Patel DH, Naeve C, Belt JA (1998) Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J Biol Chem 273:5288-5293
10. Dennis DM, Raatikainen P, Martens JR, Belardinelli L (1996) Modulation of atrioventricular nodal function by metabolic and allosteric regulators of endogenous adenosine in guinea-pig heart. Circulation 94:2551-2559
11. Galmarini CM, Mackey JR, Dumontet C (2002) Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol 3:415-424
12. Galmarini CM, Thomas X, Calvo F, Rousselot P, El Jafaari A, Cros E, Dumontet C (2002) Potential mechanisms of resistance to cytarabine in AML patients. Leuk Res 26:621-629
13. Griffith DA, Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153-181
14. Griffiths M, Beaumont N, Yao SYM, Sundaram M, Boumah CE, Davies A, Kwong FYP, Coe I, Cass CE, Young JD, Baldwin SA (1997) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med 3:89-93
15. Griffiths M, Yao SYM, Abidi F, Phillips SEV, Cass CE, Young JD, Baldwin SA (1997) Molecular Cloning and characterization of a nitrobenzylthioinosine- insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 328:739-743
16. +-nucleoside cotransporter rCNT1. J Biol Chem 276:27981-27988
17. Handa M, Choi DS, Caldeiro RM, Messing RO, Gordon AS, Diamond I (2001) Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site. Gene 262:301-307
18. Huang M, Wang Y, Cogut SB, Mitchell BS, Graves LM (2003) Inhibition of nucleoside transport by protein kinase inhibitors. J Pharmacol Exp Ther 304:753-760
19. Hyde RJ, Cass CE, Young JD, Baldwin SA (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18:53-63
20. Jennings LL, Hao CH, Cabrita MA, Vickers MF, Baldwin SA, Young JD, Cass CE (2001) Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 40:722-731
21. Keil GJ, DeLander GE (1995) Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J Pharmacol Exp Ther 274:1387-1392
22. Kiss A, Farah K, Kim J, Garriock RJ, Drysdale TA, Hammond JR (2000) Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem J 352:363-372
23. Lai YR, Bakken AH, Unadkat JD (2002) Simultaneous expression of hCNT1-CFP and hENT1-YFP in Madin-Darby canine kidney cells - localization and vectorial transport studies. J Biol Chem 277:37711-37717
24. Mackey JR, Jennings LL, Clarke ML, Santos CL, Dabbagh L, Vsianska M, Koski SL, Coupland RW, Baldwin SA, Young JD, Cass CE (2002) Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers. Clin Cancer Res 8:110-116
25. Mangravite LM, Xiao G, Giacomini KM (2003) Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. Am J Physiol (in press)
26. Martin BJ, Lasley RD, Mentzer RM (1997) Infarct size reduction with the nucleoside transport inhibitor R-75231 in swine. Am J Physiol 41:H1857-H1865
27. Meckling-Gill KA, Guilbert L, Cass CE (1993) CSF-1 stimulates nucleoside transport in S1 macrophages. J Cell Physiol 155:530-538
28. Meester BJ, Shankley NP, Welsh NJ, Meijler FL, Black JW (1998) Pharmacological analysis of the activity of the adenosine uptake inhibitor, dipyridamole, on the sinoatrial and atrioventricular nodes of the guinea-pig. Br J Pharmacol 124:729-741
29. Mubagwa K, Flameng W (2001) Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52:25-39
30. Musa H, Dobrzynski H, Berry Z, Abidi F, Cass CE, Young JD, Baldwin SA, Boyett, MR (2002) Immunocytochemical demonstration of the equilibrative nucleoside transporter rENT1 in rat sinoatrial node. J Histochem Cytochem 50:305-309
31. Poon A, Sawynok J (1998) Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 74:235-245
32. Pressacco J, Wiley JS, Jamieson GP, Erlichman C, Hedley DW (1995) Modulation of the equilibrative nucleoside transporter by inhibitors of DNA-synthesis. Br J Cancer 72:939-942
33. Reiman T, Clarke ML, Dabbagh L, Vsianska M, Coupland RW, Belch AR, Baldwin SA, Young JD, Cass CE, Mackey JR (2002) Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease. Leuk Lymph 43:1435-1440
34. Sandoval IV, Martinez-Arca S, Valdueza J, Palacios S, Holman GD (2000) Distinct reading of different structural determinants modulates the dileucine-mediated transport steps of the lysosomal membrane protein LIMPII and the insulin-sensitive glucose transporter GLUT4. J Biol Chem 275:39874-39885
35. Sawynok J (1998) Adenosine receptor activation and nociception. Eur J Pharmacol 347:1-11
36. SenGupta DJ, Lum PY, Lai YR, Shubochkina E, Bakken AH, Schneider G, Unadkat JD (2002) A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine. Biochemistry 41:1512-1519
37. Shryock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79(12A):2-10
38. Sundaram M, Yao SYM, Ng AML, Griffiths M, Cass CE, Baldwin SA, Young JD (1998) Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J Biol Chem 273:21519-21525
39. Sundaram M, Yao SY, Ng AM, Cass CE, Baldwin SA, Young JD (2001) Equilibrative nucleoside transporters: mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins. Biochemistry 40:8146-8151
40. Sundaram M, Yao SYM, Ingram JC, Berry ZA, Abidi F, Cass CE, Baldwin SA, Young JD (2001) Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs. J Biol Chem 276:45270-45275
41. + current in human airway epithelial cells by exogenous and autocrine adenosine. Am J Physiol 281:C1991-C2002
42. Tattersall MHN, Slowiaczek P, De Fazio A (1983) Regional variation in human extracellular purine levels. J Lab Clin Med 102:411-420
43. Vesa J, Peltonen L (2002) Mutated genes in juvenile and variant late infantile neuronal ceroid lipofuscinoses encode lysosomal proteins. Curr Mol Med 2:439-444
44. Vickers MF, Mani RS, Sundaram M, Hogue DL, Young JD, Baldwin SA, Cass CE (1999) Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae - Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q). Biochem J 339:21-32
45. Visser F, Vickers MF, Ng AL, Baldwin SA, Young JD, Cass CE (2002) Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole. J Biol Chem 277:395-401
46. Ward JL, Sherali A, Mo Z-P, Tse C-M (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275:8375-8381
47. Ward JL, Leung GP, Toan SV, Tse CM (2003) Functional analysis of site-directed glycosylation mutants of the human equilibrative nucleoside transporter-2. Arch Biochem Biophys 411:19-26
48. Wiley JS, Woodruff RK, Jamieson GP, Firkin FC, Sawyer WH (1987) Cytosine arabinoside in the treatment of T-cell acute lymphoblastic leukemia. Aust N Z J Med 17:379-386
49. Williams JB, Lanahan AA (1995) A mammalian delayed-early response gene encodes HNP36, a novel, conserved nucleolar protein. Biochem Biophys Res Commun 213:325-333
50. Wright AM, Gati WP, Paterson AR (2000) Enhancement of retention and cytotoxicity of 2-chlorodeoxyadenosine in cultured human leukemic lymphoblasts by nitrobenzylthioinosine, an inhibitor of equilibrative nucleoside transport. Leukemia 14:52-60
51. Yao SYM, Ng AML, Muzyka WR, Griffiths M, Cass CE, Baldwin SA, Young JD (1997) Molecular cloning and functional characterization of nitrobenzylthioinosine (NBM-PR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem 272:28423-28430
52. Yao SY, Ng AM, Sundaram M, Cass CE, Baldwin SA, Young JD (2001) Transport of antiviral 3′-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes. Mol Membr Biol 18:161-167
53. 140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2. Biochem J 353:387-393
54. Yao SYM, Ng AML, Vickers MF, Sundaram M, Cass EC, Baldwin SA, Young JD (2002) Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2 - Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation. J Biol Chem 277:24938-24948
55. Zhang YW, Shepel PN, Peeling J, Geiger JD, Parkinson FE (2002) Effects of nitrobenzylthioinosine on adenosine levels and neuronal injury in rat forebrain ischemia. Neurosci Res Commun 30:83-89